BridgeMD
New treatment option for Healthy
Official title Protein Requirements Amongst Male Masters-Level Athletes Following a Cycling Exercise Bout as Determined by the Indicator Amino Acid Oxidation Technique
ClinicalTrials.gov ID: NCT06431334
What this study is testing
- What it's testing
- Masters level cyclists are a population above the age of 35 years who frequently participate in prolonged as well as heavy-volume training. Like most endurance-trained athletes, a greater recommended dietary allowance (RDA) for protein of 1.2-1.4 g/kg/bw is suggested.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older, men only. Healthy volunteers may be eligible.
You may be able to join if
- 18.5\< BMI \<35 kg/m\^2
- Overtly healthy masters level cyclists ≥65 years
- Masters level cyclist training (\>4 days per week; \~100 km per week)
- Body mass stable over previous 6-months
- Availability for multiple metabolic trials (\~7 trials)
You likely can't join if
- Recent history of weight loss or weight gain (\>5% body weight)
- Uncontrolled hypertension
- ≥2 chronic diseases (e.g. diabetes, osteoporosis, dyslipidemia)
- Acute illness that could affect protein metabolism (HIV, renal dysfunction, influenza)
- Currently using anti-inflammatory medications
- Inability to adhere to study protocol (i.e., alcohol, caffeine, dietary restrictions)
See the full eligibility criteria
- 18.5\< BMI \<35 kg/m\^2
- Overtly healthy masters level cyclists ≥65 years
- Masters level cyclist training (\>4 days per week; \~100 km per week)
- Body mass stable over previous 6-months
- Availability for multiple metabolic trials (\~7 trials)
- Ability to travel to and from laboratory facility
- Recent history of weight loss or weight gain (\>5% body weight)
- Uncontrolled hypertension
- ≥2 chronic diseases (e.g. diabetes, osteoporosis, dyslipidemia)
- Acute illness that could affect protein metabolism (HIV, renal dysfunction, influenza)
- Currently using anti-inflammatory medications
- Inability to adhere to study protocol (i.e., alcohol, caffeine, dietary restrictions)
- Regular tobacco user
- Illicit drug use
- Habitually ingesting ≥3 g/kg/bw
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 65 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.